Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensCell Lines for BBB Modeling
- Immortalized Cells for BBB ModelingPrimary Cells for BBB ModelingStem Cells for BBB ModelingProteins & Peptides for Stroke ResearchOnline Inquiry
Mouse Angiogenin ELISA Kit (AC3085)
Cat.#: ASET-1674
Specifications
Description Mouse Angiogenin ELISA Kit, a 90-minute assay kit, allows for the in vitro quantitative determination of mouse Angiogenin concentrations in serum, plasma, and other biological fluids. Size 96T Sample Type Serum, plasma or other biological fluids. Reactivity Mouse Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.78 ng/L Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 200-3200 ng/L Assay Time ~90 min Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1688 Human VEGFC ELISA Kit (AC3099) Quantitative inquiry ASET-1455 Human Mu Opioid Receptor ELISA Kit (AC2866) Quantitative inquiry ASET-2523 Mouse SOCS2 ELISA Kit (AC3934) Quantitative inquiry ASET-1287 Rat Creatine Kinase B Type ELISA Kit (AC2698) Quantitative inquiry ASET-2045 Human MRP8 ELISA Kit (AC3456) Quantitative inquiry ASET-2398 Human Myocilin ELISA Kit (AC3809) Quantitative inquiry ASET-1698 Human Copeptin ELISA Kit (AC3109) Quantitative inquiry ASET-2230 Rat CD97 ELISA Kit (AC3641) Quantitative inquiry ASET-1520 Rat Neuroligin 3 ELISA Kit (AC2931) Quantitative inquiry ASET-1595 Human SPTBN2 ELISA Kit (AC3006) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket